Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Shares of American Eagle plummet 17% on unimpressive holiday forecast
American Eagle issued a holiday forecast that failed to impress Wall Street, following a string of retailers who’ve issued muted guidance for the season. Post Views: 169
Premature Gaza babies reach Egypt; deaths reported at Indonesian hospital
Post Content Post Views: 157
Origin Energy set to delay vote on Brookfield’s $10.6 billion bid -source
Post Content Post Views: 138
Ford to scale back plans for $3.5 billion battery plant as EV demand disappoints, labor costs rise
Ford is scaling back production capacity and expected employment at the battery plant in Michigan. Post Views: 174
Gamehost sets ex-dividend date for November 29 with CA$0.04 payout
Post Content Post Views: 125
Bitcoin Group: taking steps against money-laundering, terrorist financing
Post Content Post Views: 140